Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Kura Oncology, Inc.

KURA · Nasdaq · CIK 0001422143 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

2 qualifying P purchase groups
in the current 180-day scoring window

20 Form 4 transaction lines observed in the same window
17 sales · 1 option, withholding, award, gift or other lines

Last qualifying purchase2026-08-24 · WILSON TROY EDWARD · $1.2M

WHY NO ACTIVE SIGNAL?

Purchase activityPresent
Recent buying2 qualifying line group(s)
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Powl Brian T.Chief Commercial Officer
▼▼▼▼▼
Leoni MollieChief Medical Officer
▼▼▼
FORD KATHLEENChief Operating Officer
▼▼▼
Bair Teresa BrophyChief Legal Officer
▼▼▼
Burrows FrancisChief Scientific Officer
○▼
WILSON TROY EDWARDPresident and CEO
●●
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: WILSON TROY EDWARD · $2.4M
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-08-17–2026-08-24

Roles in the peak window: President and CEO. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-08-24 · WILSON TROY EDWARD.

Recent Form 4 activity

2Purchases
39Sales
16Other Form 4 lines
36SEC filings · 365 days
BUYING2 qualifying P line(s) · 180 days
SELLING17 sale line(s) · context only
OTHER1 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
14,419,736
Previous report
14,820,592
Avg daily volume
1,864,560
Days to cover
7.7

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-24WILSON TROY EDWARDPurchase (P)Common Stock100,000USD 12.39USD 1,239,000SEC filing ↗
2026-08-17WILSON TROY EDWARDPurchase (P)Common Stock100,000USD 11.12USD 1,112,000SEC filing ↗
2025-09-08WILSON TROY EDWARDPurchase (P)Common Stock50,000USD 8.20USD 410,000SEC filing ↗
2025-08-13WILSON TROY EDWARDPurchase (P)Common Stock13,494USD 6.64USD 89,600SEC filing ↗
2025-08-12WILSON TROY EDWARDPurchase (P)Common Stock36,506USD 5.85USD 213,560SEC filing ↗
2023-06-16Malley ThomasPurchase (P)Common stock50,000USD 11.50USD 575,000SEC filing ↗

Form 4 evidence

57 transaction lines in the latest 365-day window; 192 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-29Powl Brian T.Sale (S)Common Stock15,430USD 10.75USD 165,872SEC filing ↗
2026-09-29Leoni MollieSale (S)Common Stock28,802USD 10.75USD 309,622SEC filing ↗
2026-09-29FORD KATHLEENSale (S)Common Stock3,668USD 10.75USD 39,431SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-29Powl Brian T.Sale (S)Common Stock15,430USD 10.75USD 165,872SEC filing ↗
2026-09-29Leoni MollieSale (S)Common Stock28,802USD 10.75USD 309,622SEC filing ↗
2026-09-29FORD KATHLEENSale (S)Common Stock3,668USD 10.75USD 39,431SEC filing ↗
2026-09-28Powl Brian T.Sale (S)Common Stock17,020USD 10.53USD 179,190SEC filing ↗
2026-09-28Leoni MollieSale (S)Common Stock12,448USD 10.50USD 130,704SEC filing ↗
2026-09-28FORD KATHLEENSale (S)Common Stock6,906USD 10.50USD 72,513SEC filing ↗
2026-09-28DOYLE THOMAS JAMESSale (S)Common Stock4,607USD 10.50USD 48,374SEC filing ↗
2026-09-28Bair Teresa BrophySale (S)Common Stock8,442USD 10.50USD 88,641SEC filing ↗
2026-09-24Burrows FrancisSale (S)Common Stock20,726USD 10.83USD 224,463SEC filing ↗
2026-09-24Burrows FrancisOption exercise / conversion (M)Common Stock30,000USD 6.15USD 184,500SEC filing ↗
2026-08-24WILSON TROY EDWARDPurchase (P)Common Stock100,000USD 12.39USD 1,239,000SEC filing ↗
2026-08-21Powl Brian T.Sale (S)Common Stock4,345USD 11.89USD 51,662SEC filing ↗
2026-08-19Bair Teresa BrophySale (S)Common Stock31,487USD 12.63USD 397,681SEC filing ↗
2026-08-17WILSON TROY EDWARDPurchase (P)Common Stock100,000USD 11.12USD 1,112,000SEC filing ↗
2026-06-18Leoni MollieSale (S)Common Stock84,929USD 9.82USD 834,003SEC filing ↗
2026-05-21Powl Brian T.Sale (S)Common Stock10,000USD 11.00USD 110,000SEC filing ↗
2026-05-19Powl Brian T.Sale (S)Common Stock339USD 9.21USD 3,122SEC filing ↗
2026-05-19FORD KATHLEENSale (S)Common Stock2,257USD 9.08USD 20,494SEC filing ↗
2026-05-18Bair Teresa BrophySale (S)Common Stock2,256USD 9.38USD 21,161SEC filing ↗
2026-03-23WILSON TROY EDWARDOption exercise / conversion (M)Common Stock6,103USD 6.15USD 37,533SEC filing ↗
2026-03-18Malley ThomasOption exercise / conversion (M)Common Stock10,000USD 3.12USD 31,200SEC filing ↗
2026-01-27Powl Brian T.Sale (S)Common Stock6,414USD 8.46USD 54,262SEC filing ↗
2026-01-27Leoni MollieSale (S)Common Stock8,180USD 8.46USD 69,203SEC filing ↗
2026-01-27FORD KATHLEENSale (S)Common Stock1,813USD 8.46USD 15,338SEC filing ↗
2026-01-27DOYLE THOMAS JAMESSale (S)Common Stock4,916USD 8.46USD 41,589SEC filing ↗
2026-01-27Burrows FrancisSale (S)Common Stock1,311USD 8.46USD 11,091SEC filing ↗
2026-01-27Bair Teresa BrophySale (S)Common Stock11,208USD 8.46USD 94,820SEC filing ↗
2026-01-02Powl Brian T.Award / grant (A)Common Stock50,000USD 0.00USD 0SEC filing ↗
2026-01-02Leoni MollieAward / grant (A)Common Stock50,000USD 0.00USD 0SEC filing ↗
2026-01-02FORD KATHLEENAward / grant (A)Common Stock50,000USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerKURA
CIK0001422143
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history192 transaction lines from 2020-02-11 to 2026-09-29
6 P purchase lines · 108 S sale lines · 78 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.